LIFECORE BIOMEDICAL INC(LFCR)_个股概要_股票价格_最新资讯_行情走势_历史数据 - 老虎社区

应交易所要求，美/港股行情延时15分钟展示，下载APP即可免费查看实时行情。

关闭

LFCR LIFECORE BIOMEDICAL INC

休市中 09-11 16:00:00 EDT

4.12

+0.03

+0.73%

盘后4.12

+0.000.00%

19:30 EDT

最高4.19	最低4.06	成交量15.95万
今开4.14	昨收4.09	日振幅3.06%
总市值1.56亿	流通市值7,964万	总股本3,785万
成交额65.61万	换手率0.83%	流通股本1,933万
市净率--	ROE--	每股收益0.00
52周最高--	52周最低--	市盈率--
股息--	股息收益率--	ROA--

数据加载中...

北京优虎网络科技有限公司

{"stockData":{"symbol":"LFCR","market":"US","secType":"STK","nameCN":"LIFECORE BIOMEDICAL INC","latestPrice":4.12,"timestamp":1789156800000,"preClose":4.09,"halted":0,"volume":159515,"hourTrading":{"tag":"盘后","latestPrice":4.12,"preClose":4.12,"latestTime":"19:30 EDT","volume":2761,"amount":11375.32,"timestamp":1789169405438,"change":0,"changeRate":0,"amplitude":0},"delay":0,"changeRate":0.007334963325183435,"floatShares":19328900,"shares":37853060,"eps":-0.925714,"marketStatus":"休市中","change":0.03,"latestTime":"09-11 16:00:00 EDT","open":4.14,"high":4.185,"low":4.06,"amount":656056.003755,"amplitude":0.030562,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":0,"ttmEps":-0.925714,"tradingStatus":0,"nextMarketStatus":{"tag":"盘前交易","tradingStatus":1,"beginTime":1789372800000},"marketStatusCode":7,"adr":0,"listingDate":824274000000,"exchange":"NASDAQ","adjPreClose":4.09,"postHourTrading":{"tag":"盘后","latestPrice":4.12,"preClose":4.12,"latestTime":"19:30 EDT","volume":2761,"amount":11375.32,"timestamp":1789169405438,"change":0,"changeRate":0,"amplitude":0},"volumeRatio":0.7607486782858386,"impliedVol":0.5646,"impliedVolPercentile":0.1394},"requestUrl":"/m/hq/s/LFCR","defaultTab":"news","newsList":[{"id":"1126265365","title":"Lifecore Biomedical签署商业基地转让协议，支持全球制药公司","url":"https://stock-news.laohu8.com/highlight/detail?id=1126265365","media":"美股速递","labels":["corporation"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1126265365?lang=zh_cn&edition=full","pubTime":"2026-09-02 19:13","pubTimestamp":1788347594,"startTime":"0","endTime":"0","summary":"Lifecore Biomedical已签署一项商业基地转让协议，旨在为一家全球性制药企业提供支持。这项协议的达成，标志着该公司在战略布局上迈出了重要一步。通过转让商业基地，Lifecore Biomedical将协助该制药公司实现业务的无缝对接与持续运营。此举不仅体现了Lifecore Biomedical在行业内的专业实力，也进一步巩固了其作为合作伙伴的可靠地位。协议的签署，为双方未来的协同发展奠定了坚实基础，同时也为市场带来了新的期待。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LFCR","BK4121","BK4212"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1108950927","title":"Lifecore Biomedical公布2026财年第一季度业绩并更新公司动态","url":"https://stock-news.laohu8.com/highlight/detail?id=1108950927","media":"美股速递","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1108950927?lang=zh_cn&edition=full","pubTime":"2026-05-06 19:09","pubTimestamp":1778065753,"startTime":"0","endTime":"0","summary":"Lifecore Biomedical Inc（股票代码：LFCR）近日披露了截至2026年3月31日的第一季度财务报告，同时向市场同步了公司最新运营进展。\n这家专注于生物医学领域的公司通过季报展现了本财年开局阶段的经营成果。此次披露不仅涵盖关键财务数据，还涉及战略规划与业务发展方面的最新信息，为投资者评估企业现状与未来潜力提供了重要依据。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LFCR","BK4212","BK4121"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2514090138","title":"Lifecore Biomedical, Inc.盘中异动 急速拉升6.43%","url":"https://stock-news.laohu8.com/highlight/detail?id=2514090138","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2514090138?lang=zh_cn&edition=full","pubTime":"2025-02-25 22:37","pubTimestamp":1740494269,"startTime":"0","endTime":"0","summary":"北京时间2025年02月25日22时37分，Lifecore Biomedical, Inc.股票出现波动，股价大幅上涨6.43%。Lifecore Biomedical, Inc.股票所在的制药行业中，整体涨幅为1.46%。Lifecore Biomedical, Inc.公司简介：Lifecore Biomedical Inc是一家全面整合的合同开发和生产组织，在注射器和小瓶中的复杂无菌注射药品的开发、灌装和精加工方面提供差异化的能力。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025022522374998924e1d&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025022522374998924e1d&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LFCR","BK4139","BK4121","CDMO","BK4212"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2506568588","title":"Lifecore Biomedical, Inc.盘中异动 股价大跌5.06%报6.00美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2506568588","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2506568588?lang=zh_cn&edition=full","pubTime":"2025-01-28 01:27","pubTimestamp":1737998821,"startTime":"0","endTime":"0","summary":"北京时间2025年01月28日01时27分，Lifecore Biomedical, Inc.股票出现异动，股价快速下跌5.06%。截至发稿，该股报6.00美元/股，成交量3.105万股，换手率0.08%，振幅5.06%。Lifecore Biomedical, Inc.股票所在的制药行业中，整体涨幅为2.25%。Lifecore Biomedical, Inc.公司简介：Lifecore Biomedical Inc是一家全面整合的合同开发和生产组织，在注射器和小瓶中的复杂无菌注射药品的开发、灌装和精加工方面提供差异化的能力。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250128012701a2318e47&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250128012701a2318e47&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["TKNO","BK4139","CDMO","BK4212","LFCR","BK4539","BK4121"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2505432023","title":"Lifecore Biomedical, Inc.盘中异动 股价大跌5.13%报6.10美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2505432023","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2505432023?lang=zh_cn&edition=full","pubTime":"2025-01-24 04:22","pubTimestamp":1737663720,"startTime":"0","endTime":"0","summary":"北京时间2025年01月24日04时22分，Lifecore Biomedical, Inc.股票出现波动，股价快速下挫5.13%。Lifecore Biomedical, Inc.股票所在的制药行业中，整体涨幅为0.69%。其相关个股中，Cbdmd, Inc.、阿玛琳、Eton Pharmaceuticals, Inc.涨幅较大，Cbdmd, Inc.、Inmed Pharmaceuticals Inc.、Painreform Ltd.较为活跃，换手率分别为48.53%、34.22%、19.86%，振幅较大的相关个股有Cbdmd, Inc.、Petros Pharmaceuticals, Inc.、Gelteq Limited，振幅分别为26.13%、19.84%、18.55%。Lifecore Biomedical, Inc.公司简介：Lifecore Biomedical Inc是一家全面整合的合同开发和生产组织，在注射器和小瓶中的复杂无菌注射药品的开发、灌装和精加工方面提供差异化的能力。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250124042200a22d4db6&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250124042200a22d4db6&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["CDMO","BK4121","LFCR","BK4212","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2502862870","title":"Lifecore Biomedical, Inc.盘中异动 股价大涨5.00%报6.09美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2502862870","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2502862870?lang=zh_cn&edition=full","pubTime":"2025-01-10 22:32","pubTimestamp":1736519537,"startTime":"0","endTime":"0","summary":"北京时间2025年01月10日22时32分，Lifecore Biomedical, Inc.股票出现异动，股价快速拉升5.00%。Lifecore Biomedical, Inc.股票所在的制药行业中，整体涨幅为0.10%。Lifecore Biomedical, Inc.公司简介：Lifecore Biomedical Inc是一家全面整合的合同开发和生产组织，在注射器和小瓶中的复杂无菌注射药品的开发、灌装和精加工方面提供差异化的能力。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250110223217aba602bc&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250110223217aba602bc&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4121","BK4212","BK4139","CDMO","LFCR"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2501778863","title":"Lifecore Biomedical, Inc.盘中异动 大幅下挫5.82%报6.47美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2501778863","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2501778863?lang=zh_cn&edition=full","pubTime":"2025-01-07 22:42","pubTimestamp":1736260959,"startTime":"0","endTime":"0","summary":"北京时间2025年01月07日22时42分，Lifecore Biomedical, Inc.股票出现异动，股价大幅下挫5.82%。Lifecore Biomedical, Inc.股票所在的制药行业中，整体涨幅为0.23%。Lifecore Biomedical, Inc.公司简介：Lifecore Biomedical Inc是一家全面整合的合同开发和生产组织，在注射器和小瓶中的复杂无菌注射药品的开发、灌装和精加工方面提供差异化的能力。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250107224239aba1e1dc&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250107224239aba1e1dc&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4007","PTPI","BK4121","LFCR","BK4139","CDMO","BK4212"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2501129643","title":"Lifecore Biomedical（LFCR.O）：2025年Q2营收3260万美元，净亏损660万美元，实施增长战略，产能翻倍至3亿美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2501129643","media":"市场资讯","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2501129643?lang=zh_cn&edition=full","pubTime":"2025-01-07 06:41","pubTimestamp":1736203260,"startTime":"0","endTime":"0","summary":"01. Lifecore Biomedical（LFCR.O）业绩电话会：2025年Q2，公司营收3260万美元，同比增长8%，毛利润1110万美元，增加110万美元。销售管理费用1110万美元，净亏损660万美元。上半年营收5730万美元，增长5%，毛利润1650万美元，增加380万美元。净亏损2280万美元。公司实施增长战略，目标12%营收复合年增长，EBITDA利润率超25%。业务开发管道增长，与大型跨国公司合作增多。产能翻倍至3亿美元，任命新高管以降低成本、保持品质。毛利率预计全年约30%，债务约1.6亿美元。\n\n\n\n\n\n\n\n\n\n海量资讯、精准解读，尽在新浪财经APP","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.sina.com.cn/roll/2025-01-07/doc-ineeautf2488693.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"sina","symbols":["LFCR"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2501256265","title":"Lifecore Biomedical, Inc.盘中异动 早盘股价大跌5.25%","url":"https://stock-news.laohu8.com/highlight/detail?id=2501256265","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2501256265?lang=zh_cn&edition=full","pubTime":"2025-01-06 23:11","pubTimestamp":1736176315,"startTime":"0","endTime":"0","summary":"北京时间2025年01月06日23时11分，Lifecore Biomedical, Inc.股票出现波动，股价快速下挫5.25%。Lifecore Biomedical, Inc.股票所在的制药行业中，整体跌幅为0.30%。Lifecore Biomedical, Inc.公司简介：Lifecore Biomedical Inc是一家全面整合的合同开发和生产组织，在注射器和小瓶中的复杂无菌注射药品的开发、灌装和精加工方面提供差异化的能力。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250106231156985cef7c&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250106231156985cef7c&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4121","BK4212","CDMO","BK4139","LFCR"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2501244089","title":"Lifecore Biomedical（LFCR.O）：2025年Q2营收3260万美元，同比增长8%，完成股票发行增强流动性","url":"https://stock-news.laohu8.com/highlight/detail?id=2501244089","media":"市场资讯","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2501244089?lang=zh_cn&edition=full","pubTime":"2025-01-06 06:41","pubTimestamp":1736116860,"startTime":"0","endTime":"0","summary":"01. Lifecore Biomedical（LFCR.O）业绩电话会：2025年Q2，公司营收3260万美元，同比增长8%，毛利润1110万美元，增加110万美元，净亏损660万美元。上半年营收增长5%，毛利润增加380万美元，净亏损2280万美元。完成2430万美元股票发行，增强流动性。公司增长战略目标为12%营收复合年增长率，EBITDA利润率超25%。业务渠道增长，特别是大型跨国公司业务，占渠道的30%以上。\n\n\n\n海量资讯、精准解读，尽在新浪财经APP","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.sina.com.cn/roll/2025-01-06/doc-inecyrue8813194.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"sina","symbols":["LFCR"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2500111248","title":"Lifecore Biomedical, Inc.盘中异动 股价大涨6.46%报7.09美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2500111248","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2500111248?lang=zh_cn&edition=full","pubTime":"2025-01-03 22:31","pubTimestamp":1735914665,"startTime":"0","endTime":"0","summary":"北京时间2025年01月03日22时31分，Lifecore Biomedical, Inc.股票出现波动，股价快速拉升6.46%。Lifecore Biomedical, Inc.股票所在的制药行业中，整体涨幅为0.00%。其相关个股中，Scilex Holding Company C/Wts 10/11/2027 、Therapeuticsmd, Inc.、Cbdmd, Inc.涨幅较大，Painreform Ltd.、Therapeuticsmd, Inc.、Cbdmd, Inc.较为活跃，换手率分别为6.13%、5.43%、5.41%，振幅较大的相关个股有Therapeuticsmd, Inc.、Cbdmd, Inc.、Lifecore Biomedical, Inc.，振幅分别为9.03%、5.31%、4.80%。Lifecore Biomedical, Inc.公司简介：Lifecore Biomedical Inc是一家全面整合的合同开发和生产组织，在注射器和小瓶中的复杂无菌注射药品的开发、灌装和精加工方面提供差异化的能力。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250103223105a2146897&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250103223105a2146897&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LFCR","BK4121","CDMO","BK4212","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2500907359","title":"Lifecore Biomedical(LFCR.US)：2025年Q2财报实现营收3256.4万美元，前值为3015万美元，预期值为2975万美元；每股收益为-0.25美元，前值为0.39美元，预期值为-0.31美元。","url":"https://stock-news.laohu8.com/highlight/detail?id=2500907359","media":"金融界","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2500907359?lang=zh_cn&edition=full","pubTime":"2025-01-03 05:23","pubTimestamp":1735853025,"startTime":"0","endTime":"0","summary":"Lifecore Biomedical(LFCR.US)：2025年Q2财报实现营收3256.4万美元，前值为3015万美元，预期值为2975万美元；每股收益为-0.25美元，前值为0.39美元，预期值为-0.31美元。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://24h.jrj.com.cn/2025/01/03052347069557.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"jinrongjie_stock","symbols":["LFCR"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1129087770","title":"Lifecore Biomedical 2025年第二季度GAAP每股收益$(0.25)优于预期$(0.29)，销售额$3260万高于预期$2975万","url":"https://stock-news.laohu8.com/highlight/detail?id=1129087770","media":"财报速递","labels":["express"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1129087770?lang=zh_cn&edition=full","pubTime":"2025-01-03 05:08","pubTimestamp":1735852100,"startTime":"0","endTime":"0","summary":"Lifecore Biomedical 报告季度每股亏损$，优于分析师普遍预期的$，差异率为13.79%。公司报告季度销售额为$3260万，超过分析师普遍预期的$2975万，差异率为9.59%。与去年同期的$3015万相比，这一销售额增长了8.13%。以上内容来自Benzinga Earnings专栏，原文如下：Lifecore Biomedical  reported quarterly losses of $ per share which beat the analyst consensus estimate of $ by 13.79 percent.  The company reported quarterly sales of $32.60 million which beat the analyst consensus estimate of $29.75 million by 9.59 percent.  This is a 8.13 percent increase over sales of $30.15 million the same period last ","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":"Lifecore Biomedical 2025年第二季度GAAP每股收益$(0.25)优于预期$(0.29)，销售额$3260万高于预期$2975万","news_tag":"express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LFCR"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2500920062","title":"Lifecore Biomedical, Inc.盘中异动 早盘股价大跌5.25%报7.04美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2500920062","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2500920062?lang=zh_cn&edition=full","pubTime":"2025-01-02 23:08","pubTimestamp":1735830508,"startTime":"0","endTime":"0","summary":"北京时间2025年01月02日23时08分，Lifecore Biomedical, Inc.股票出现波动，股价大幅下挫5.25%。截至发稿，该股报7.04美元/股，成交量5.0757万股，换手率0.14%，振幅4.71%。Lifecore Biomedical, Inc.股票所在的制药行业中，整体涨幅为1.18%。Lifecore Biomedical, Inc.公司简介：Lifecore Biomedical Inc是一家全面整合的合同开发和生产组织，在注射器和小瓶中的复杂无菌注射药品的开发、灌装和精加工方面提供差异化的能力。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250102230828a2130aa3&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250102230828a2130aa3&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["CDMO","BK4212","LFCR","BK4121","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2494355503","title":"Lifecore Biomedical, Inc.盘中异动 急速下跌5.01%","url":"https://stock-news.laohu8.com/highlight/detail?id=2494355503","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2494355503?lang=zh_cn&edition=full","pubTime":"2024-12-28 01:46","pubTimestamp":1735321593,"startTime":"0","endTime":"0","summary":"北京时间2024年12月28日01时46分，Lifecore Biomedical, Inc.股票出现波动，股价快速下挫5.01%。Lifecore Biomedical, Inc.股票所在的制药行业中，整体跌幅为0.99%。Lifecore Biomedical, Inc.公司简介：Lifecore Biomedical Inc是一家全面整合的合同开发和生产组织，在注射器和小瓶中的复杂无菌注射药品的开发、灌装和精加工方面提供差异化的能力。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202412280146349851fb12&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202412280146349851fb12&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","BK4212","CDMO","BK4121","LFCR"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2493853038","title":"Lifecore Biomedical, Inc.盘中异动 股价大涨5.41%","url":"https://stock-news.laohu8.com/highlight/detail?id=2493853038","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2493853038?lang=zh_cn&edition=full","pubTime":"2024-12-24 23:04","pubTimestamp":1735052645,"startTime":"0","endTime":"0","summary":"北京时间2024年12月24日23时04分，Lifecore Biomedical, Inc.股票出现波动，股价急速拉升5.41%。Lifecore Biomedical, Inc.股票所在的制药行业中，整体跌幅为0.69%。Lifecore Biomedical, Inc.公司简介：Lifecore Biomedical Inc是一家全面整合的合同开发和生产组织，在注射器和小瓶中的复杂无菌注射药品的开发、灌装和精加工方面提供差异化的能力。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241224230405984d8afc&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241224230405984d8afc&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4121","LFCR","BK4139","BK4212","CDMO"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2492159465","title":"Lifecore Biomedical, Inc.盘中异动 临近收盘快速跳水5.15%","url":"https://stock-news.laohu8.com/highlight/detail?id=2492159465","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2492159465?lang=zh_cn&edition=full","pubTime":"2024-12-19 04:38","pubTimestamp":1734554293,"startTime":"0","endTime":"0","summary":"北京时间2024年12月19日04时38分，Lifecore Biomedical, Inc.股票出现波动，股价大幅下挫5.15%。Lifecore Biomedical, Inc.股票所在的制药行业中，整体跌幅为1.41%。Lifecore Biomedical, Inc.公司简介：Lifecore Biomedical Inc是一家全面整合的合同开发和生产组织，在注射器和小瓶中的复杂无菌注射药品的开发、灌装和精加工方面提供差异化的能力。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241219043813ab829f9c&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241219043813ab829f9c&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["CDMO","BK4121","BK4139","LFCR","BK4212"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2491037957","title":"Lifecore Biomedical, Inc.盘中异动 早盘快速下挫5.14%报7.19美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2491037957","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2491037957?lang=zh_cn&edition=full","pubTime":"2024-12-13 23:01","pubTimestamp":1734102111,"startTime":"0","endTime":"0","summary":"北京时间2024年12月13日23时01分，Lifecore Biomedical, Inc.股票出现波动，股价大幅下跌5.14%。截至发稿，该股报7.19美元/股，成交量6043股，换手率0.02%，振幅3.83%。Lifecore Biomedical, Inc.股票所在的制药行业中，整体跌幅为0.03%。Lifecore Biomedical, Inc.公司简介：Lifecore Biomedical Inc是一家全面整合的合同开发和生产组织，在注射器和小瓶中的复杂无菌注射药品的开发、灌装和精加工方面提供差异化的能力。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241213230151ab759b7a&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241213230151ab759b7a&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4539","BK4007","BK4139","CDMO","BK4183","BK4212","LFCR","FLGC","BK4121"],"isVideo":false,"video":null,"gpt_icon":1},{"id":"2490338766","title":"Lifecore Biomedical, Inc.盘中异动 大幅下跌5.15%","url":"https://stock-news.laohu8.com/highlight/detail?id=2490338766","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2490338766?lang=zh_cn&edition=full","pubTime":"2024-12-12 23:43","pubTimestamp":1734018237,"startTime":"0","endTime":"0","summary":"北京时间2024年12月12日23时43分，Lifecore Biomedical, Inc.股票出现异动，股价急速下挫5.15%。Lifecore Biomedical, Inc.股票所在的制药行业中，整体跌幅为0.29%。Lifecore Biomedical, Inc.公司简介：Lifecore Biomedical Inc是一家全面整合的合同开发和生产组织，在注射器和小瓶中的复杂无菌注射药品的开发、灌装和精加工方面提供差异化的能力。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024121223435795e939c8&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024121223435795e939c8&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4212","LFCR","CDMO","BK4139","BK4121"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2490896470","title":"Lifecore Biomedical, Inc.盘中异动 下午盘大幅上涨5.01%报7.65美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2490896470","media":"市场透视","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2490896470?lang=zh_cn&edition=full","pubTime":"2024-12-12 02:07","pubTimestamp":1733940434,"startTime":"0","endTime":"0","summary":"北京时间2024年12月12日02时07分，Lifecore Biomedical, Inc.股票出现波动，股价急速上涨5.01%。Lifecore Biomedical, Inc.股票所在的制药行业中，整体跌幅为0.47%。Lifecore Biomedical, Inc.公司简介：Lifecore Biomedical Inc是一家全面整合的合同开发和生产组织，在注射器和小瓶中的复杂无菌注射药品的开发、灌装和精加工方面提供差异化的能力。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024121202071495e900a4&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024121202071495e900a4&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4212","CDMO","BK4139","BK4121","LFCR"],"isVideo":false,"video":null,"gpt_icon":0}],"profile":{"websiteUrl":"http://www.lifecore.com","stockEarnings":[{"period":"1week","weight":-0.0636},{"period":"1month","weight":-0.1363},{"period":"3month","weight":-0.2695},{"period":"6month","weight":-0.37},{"period":"1year","weight":-0.4698},{"period":"ytd","weight":-0.4963}],"compareEarnings":[{"period":"1week","weight":-0.0077},{"period":"1month","weight":-0.0106},{"period":"3month","weight":0.0304},{"period":"6month","weight":0.154},{"period":"1year","weight":0.1622},{"period":"ytd","weight":0.1208}],"compareStock":{"symbol":"SPY","name":"标普500ETF"},"description":"Lifecore Biomedical, Inc.于1986年10月31日在加利福尼亚州注册成立，并于2008年11月6日重新注册为特拉华州公司。该公司及其子公司为食品和生物材料市场设计、开发、制造和销售差异化产品，并向合作伙伴许可技术应用。该公司已发展成为美国领先的药用级非动物源透明质酸 (HA) 生产商，采用其于1981年开发的专有发酵工艺。Lifecore生产散装透明质酸，以及用于配制和灌装注射剂的注射器和安瓿瓶，这些注射剂可用于治疗包括眼科和骨科在内的多种疾病。此外，Lifecore还运用其在HA生产方面的专业知识，与客户合作，为各种应用创造了高粘度非HA基无菌注射产品。","yearOnYearQuotes":[{"month":1,"riseRate":0.433333,"avgChangeRate":0.014109},{"month":2,"riseRate":0.433333,"avgChangeRate":-0.008997},{"month":3,"riseRate":0.612903,"avgChangeRate":0.010835},{"month":4,"riseRate":0.516129,"avgChangeRate":0.022252},{"month":5,"riseRate":0.677419,"avgChangeRate":0.048284},{"month":6,"riseRate":0.516129,"avgChangeRate":0.005367},{"month":7,"riseRate":0.354839,"avgChangeRate":-0.014463},{"month":8,"riseRate":0.516129,"avgChangeRate":0.000151},{"month":9,"riseRate":0.387097,"avgChangeRate":0.00141},{"month":10,"riseRate":0.366667,"avgChangeRate":-0.007015},{"month":11,"riseRate":0.5,"avgChangeRate":0.007022},{"month":12,"riseRate":0.533333,"avgChangeRate":0.010193}],"exchange":"NASDAQ","name":"LIFECORE BIOMEDICAL INC","nameEN":"LIFECORE BIOMEDICAL INC"},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"isLaohu8Offline":false,"tenantId":"TBCN","deviceId":"web-server-community-laohu8-v3","version":"4.44.1","shortVersion":"4.44.1","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"LIFECORE BIOMEDICAL INC(LFCR)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供LIFECORE BIOMEDICAL INC(LFCR)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"LIFECORE BIOMEDICAL INC,LFCR,LIFECORE BIOMEDICAL INC股票,LIFECORE BIOMEDICAL INC股票老虎,LIFECORE BIOMEDICAL INC股票老虎国际,LIFECORE BIOMEDICAL INC行情,LIFECORE BIOMEDICAL INC股票行情,LIFECORE BIOMEDICAL INC股价,LIFECORE BIOMEDICAL INC股市,LIFECORE BIOMEDICAL INC股票价格,LIFECORE BIOMEDICAL INC股票交易,LIFECORE BIOMEDICAL INC股票购买,LIFECORE BIOMEDICAL INC股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"LIFECORE BIOMEDICAL INC(LFCR)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供LIFECORE BIOMEDICAL INC(LFCR)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}